The presence and clearance of immune complexes in the untreated generalised psoriasis

International Journal of Immunopathology and Pharmacology

Volumn 11, Issue 2, 1998, Pages 91-99

  Ahangari, G ^a,b,c   Rakhshan, M ^f   Farhoudi, A ^c   Eslami, M B ^e   Mortazavi, H ^d   Pakzad, P ^f  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

^f Beheshti University   (Iran)

Author keywords

Clearance; Immune complex; Psoriasis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031660142     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463209801100207     Document Type: Article

References (27)

1. Baker B. S. and L. Fry. 1992. The immunology of psoriasis. Br. J. Dermatol. 126:1
2. Baadsgaard, o., G. Fisher, J. Voohrhees, and K. Cooper. 1990. The role of the immune system in the pathogenesis of psoriasis. J. Invest. Dermatol. 95:32
3. + immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. Arch. Dermatol. Res. 286:87
4. Beynon H. L. C., K. A. Davies, D. O. Haskard and M. J. Walport. 1994. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils and endothelium. J. Immunol. 153:3160
5. Cochrane C. G. 1963. Studies on location of antigen-antibody complexes and other macromolecules in vessels. J. Exp. Med. 142:242
6. Davies K. A., J. A. Shifferli and M. J. Walport. 1994. Complement deficiency and immune complex disease. Immunopathol. 15:397
7. Ross G. D. and M. E. Medof. 1985. Membrane complement receptor specific for bound fragments of C3. Adv. Immunol. 37:217
8. Fearon D.T. 1988. CR1 (the C3b receptor) and CR2 (the C3d/EBV receptor) in immunological disease. In: Clinical immunology and allergy. Complement and immunological disease. Kazatchkine, M. D. Bailliere ed., Tindall, London, 2: p. 433
9. Cornacof J. B., L. A. Hebert and W. L. Smead. 1983. Primate erythrocyte immune complex-clearing mechanism. J. Clin. Invest. 71: 236
10. Ehlenberger A. G. and V. Nussenzweig. 1977. The role of membrane receptors for C3b and C3d in phagocytosis. J. Exp. Med. 145:356
11. Weiss L., J. F. Delfraissy and A. Vasquez. 1987. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. J. Immunol. 138: 2988
12. Schifferli J. A., Y. C. Ng, J. Estreicher and J. M. Walport. 1988. The clearance of tetanus toxoid/anti-tetanus immune complexes from the circulation of humans. J. Immunol. 140: 899
13. Miyakawa Y., A. Yamada, K. Kosaka, F. Tsuda, E. Kosugi and M. Mayumi. 1981. Defective immune adherence receptor(C3b) on erythrocytes from patients with systemic lupus erythematosus. Lancet. 2: 493
14. Corretta A., G. Pomponio, R. Bencivenga, M. M. Luchetti, M. Spycher, P. J. Speth and G. Danieli. 1991. Low number of complement C3b/C4b receptor(CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, Systemic lupus erythematosus and Rheumatoid arthritis: Relationship with disease activity, anticardilipin antibodies, complement activation and therapy. J. Rheumatol. 18:1021
15. Cohen J. M., J. P. Aubry, M. H. Jouvin, J. Wijdenes, J. Banchereau, M. D. Kazatchkine and J. P. Revillard. 1987. Enumeration of CR1 Complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flowcytometry. J. Immunol. Methods. 99:53
16. Lobatto S. M. R. Daha, and A. A. Voetman. 1987. Clearance of soluble aggregates of human immunoglobulin in healthy volunteers and chimpanzees. Clin. Exp. Immunol. 75:329
17. Daha M. R., R. M. Bertina and J. Thompson. 1982. Combined hereditary deficiency of the Sixth component of complement and factor VIII coagulant activity in Dutch family. Clin. Exp. Immunol. 48:733
18. Shifferli J. A., U. C. Ng, J. P. Paccaud and M. J. Walport. 1989. The role of hypocomplementaemia and low erythrocyte complement receptor type1 number in determining abnormal immune complex clearance in humans. Clin. Exp. Immunol. 75:329
19. Shiferli J. A., and R. P. Taylor. 1989. Physiological and pathological aspects of circulating immune complexes. Kidney. Int. 35: 993
20. Walport M. J., G. D. Ross, C. M. Worth-Young, J. V. Watson, N. Hogg and P. J. Lachmann. 1985. Family studies of erythrocyte complement receptor type1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin. Exp. Immunol. 59:547
21. Davis K. A., A. M. Peters, H. L. C. Beynon and M. J. Walport. 1992. Immune complex processing in patients with systemic lupus erythematosus: In vivo imaging and clearance studies. J. Clin. Invest. 90:2075
22. Kilpatrick J. M., B. Hyman and G. Virella. 1987. Human endothelial cell damage induced by interactions between polymorphonuclear leukocytes and immune complex coated erythrocytes. Clin. Immunol and Immunopathol. 44:335.
23. Walport M. J. and P. Lachman. 1988. Erythrocyte complement receptor type1(CR1), immune complexes and the rheumatic disease. Arthritis. Rheum. 31:153
24. Ross G. D. and M. E. Medof. 1985. Membrane complement receptors specific for bound fragments of C3. Adv. Immunol. 37:217
25. Ruuska, P. K., I. Ikäheimo, S. Silvennoinen-kassinen, M. L. Käär and A. Tillikainen. 1992. Normal C3b receptor(CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus(IDDM): is the low erythrocyte CR1 expression an acquired phenomenon? Clin. Exp. Immunol. 89:18
26. Munson L. G., M. E. Scott, A. L. Landy and G. T. Spear. 1995. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. Clin. Immunol and Immunopathol. 75:20
27. Gibson, N. C. and F. J. Waxman. 1994. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1(CR1/CD35) on human erythrocytes. Clin. Immunol. and Immunopathol. 70:104